Skip to main content
RCMT $35.05 +21.20%
RCMT logo

RCMT · Rcm Technologies, Inc.

Track RCMT — free
$35.05 +6.13 (+21.20%) At close · Aug 14
Market Cap
$249.23M
Shares
7.11M
All earnings calls

Earnings call · FY2025 Q2

Rcm Technologies, Inc. Q2 FY2025 Earnings Call

Rcm Technologies, Inc. Q2 FY2025 Earnings Call

Concluded Aug 7, 2024
Aug 7, 2024 46 turns
Period
FY2025 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Financial Performance 16 Dividend / Capital Return Considerations 12 Engineering & Energy Services 10 Aerospace and Defense 9 Life Sciences, Data and Solutions 8 Health Care Services / Education Staffing 6

Management tone

Confident

Net tone +78 · low hedging

Grounding quotes
  • “We are pleased to report that the Health Care Services Group closed out the 2024/2025 school year with strong momentum.”
  • “We anticipate a record year for the Aerospace and Defense Group in 2025.”
  • “Our engineering teams remain in the forefront of enabling next-generation energy solutions, positioning RCM as a trusted partner in an increasingly complex, opportunity-rich market.”
  • “Adjusted EBITDA for Q2 2025 was $8.1 million, up from $7.2 million in Q2 2024, which is a growth of 12.9%.”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $78.17M +13% YoY
Diluted EPS $0.50 +6.4% YoY
Gross margin 28.5% -0.4 pp YoY
Net income $3.79M +0.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 7, 2024

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Normalized gross margins (Engineering)
full year (normalized)
22% – 26%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Specialty Health Care$42.82M +15.9% YoY
Engineering$26.52M +17.8% YoY
Life Sciences Data Solutions$8.82M -9.3% YoY
Corporate$0

Capital returned

Buybacks · derived
$1.93M
Full-screen source Call document